在印度北部,基于伊弗梅克的大规模治疗的药物管理:单臂社区干预试验
Daniel Engelman1,2,3, Rajesh Singh4, Hannah J Woodall5
1Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Open forum infectious diseases
|October 21, 2024
概括
随着ivermectin的大规模药物管理,在中等流行地区显著降低了和impetigo的流行率. 这种干预措施对在类似环境中控制这些皮肤感染有希望.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 皮肤病学 皮肤病学
背景情况:
- 和impetigo导致严重的健康问题和并发症.
- 艾弗梅克丁大规模药物管理在高流行岛屿环境中是有效的.
- 它在中度流行地区的有效性仍然是未知的.
研究的目的:
- 为了评估基于ivermectin的大规模药物管理的有效性.
- 评估在中等流行地区对和impetigo患病率的影响.
- 确定全社区干预的可行性.
主要方法:
- 进行了一项单臂,前后社区干预试验.
- 对整个村庄的人口提供了口服ivermectin或局部permethrin的大规模药物管理.
- 在临床标准的使用下,在基线和12个月评估了疹和疹发病率.
主要成果:
- 治疗覆盖率高 (第一剂99.4%,第二剂97.2%).
- 的发病率从7.5%降至0.9% (87.7%的减少).
- 冲发病率从1.2%降至0.4% (减少66.1%).
结论:
- 基于伊弗梅克丁的大规模药物管理有效地减少了和impetigo的流行率.
- 该干预在印度北部中等流行环境中取得了成功.
- 这种方法为控制这些皮肤感染提供了一个可行的策略.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103


